244 related articles for article (PubMed ID: 31680725)
1. Postablation Immune Microenvironment: Synergy between Interventional Oncology and Immuno-oncology.
Kim D; Erinjeri JP
Semin Intervent Radiol; 2019 Oct; 36(4):334-342. PubMed ID: 31680725
[TBL] [Abstract][Full Text] [Related]
2.
Kim NJ; Yoon JH; Tuomi AC; Lee J; Kim D
Front Immunol; 2023; 14():1118845. PubMed ID: 36969248
[TBL] [Abstract][Full Text] [Related]
3. Interventional Oncology and Immuno-Oncology: Current Challenges and Future Trends.
Posa A; Contegiacomo A; Ponziani FR; Punzi E; Mazza G; Scrofani A; Pompili M; Goldberg SN; Natale L; Gasbarrini A; Sala E; Iezzi R
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108507
[TBL] [Abstract][Full Text] [Related]
4. Radiofrequency ablation of liver metastasis: potential impact on immune checkpoint inhibitor therapy.
Minami Y; Nishida N; Kudo M
Eur Radiol; 2019 Sep; 29(9):5045-5051. PubMed ID: 30963271
[TBL] [Abstract][Full Text] [Related]
5. How Compatible Are Immune Checkpoint Inhibitors and Thermal Ablation for Liver Metastases?
Minami Y; Takaki H; Yamakado K; Kudo M
Cancers (Basel); 2022 Apr; 14(9):. PubMed ID: 35565338
[TBL] [Abstract][Full Text] [Related]
6. Contribution of immune cells in synergistic anti-tumor effect of ablation and immunotherapy.
He N; Jiang J
Transl Oncol; 2024 Feb; 40():101859. PubMed ID: 38070356
[TBL] [Abstract][Full Text] [Related]
7. Immuno-oncology and interventional oncology: a winning combination. The latest scientific evidence.
Lucatelli P; Iezzi R; De Rubeis G; Goldberg SN; Bilbao JI; Sami A; Akhan O; Giuliante F; Pompili M; Tagliaferri L; Valentini V; Gasbarrini A; Colosimo C; Bezzi M; Manfredi R
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5343-5350. PubMed ID: 31298386
[TBL] [Abstract][Full Text] [Related]
8. Immuno-oncology and Its Opportunities for Interventional Radiologists: Immune Checkpoint Inhibition and Potential Synergies with Interventional Oncology Procedures.
Hickey RM; Kulik LM; Nimeiri H; Kalyan A; Kircher S; Desai K; Riaz A; Lewandowski RJ; Salem R
J Vasc Interv Radiol; 2017 Nov; 28(11):1487-1494. PubMed ID: 28912090
[TBL] [Abstract][Full Text] [Related]
9. Novel Immune Stimulant Amplifies Direct Tumoricidal Effect of Cancer Ablation Therapies and Their Systemic Antitumor Immune Efficacy.
Korbelik M; Hode T; Lam SSK; Chen WR
Cells; 2021 Feb; 10(3):. PubMed ID: 33668932
[TBL] [Abstract][Full Text] [Related]
10. Thermal and mechanical high-intensity focused ultrasound: perspectives on tumor ablation, immune effects and combination strategies.
van den Bijgaart RJ; Eikelenboom DC; Hoogenboom M; Fütterer JJ; den Brok MH; Adema GJ
Cancer Immunol Immunother; 2017 Feb; 66(2):247-258. PubMed ID: 27585790
[TBL] [Abstract][Full Text] [Related]
11. Intratumoral Immunotherapy and Tumor Ablation: A Local Approach with Broad Potential.
Senders ZJ; Martin RCG
Cancers (Basel); 2022 Mar; 14(7):. PubMed ID: 35406525
[TBL] [Abstract][Full Text] [Related]
12. Role of noninvasive molecular imaging in determining response.
Marciscano AE; Thorek DLJ
Adv Radiat Oncol; 2018; 3(4):534-547. PubMed ID: 30370353
[TBL] [Abstract][Full Text] [Related]
13. Antibody-Drug Conjugates Bearing Pyrrolobenzodiazepine or Tubulysin Payloads Are Immunomodulatory and Synergize with Multiple Immunotherapies.
Rios-Doria J; Harper J; Rothstein R; Wetzel L; Chesebrough J; Marrero A; Chen C; Strout P; Mulgrew K; McGlinchey K; Fleming R; Bezabeh B; Meekin J; Stewart D; Kennedy M; Martin P; Buchanan A; Dimasi N; Michelotti E; Hollingsworth R
Cancer Res; 2017 May; 77(10):2686-2698. PubMed ID: 28283653
[TBL] [Abstract][Full Text] [Related]
14. Non-thermal histotripsy tumor ablation promotes abscopal immune responses that enhance cancer immunotherapy.
Qu S; Worlikar T; Felsted AE; Ganguly A; Beems MV; Hubbard R; Pepple AL; Kevelin AA; Garavaglia H; Dib J; Toma M; Huang H; Tsung A; Xu Z; Cho CS
J Immunother Cancer; 2020 Jan; 8(1):. PubMed ID: 31940590
[TBL] [Abstract][Full Text] [Related]
15. In situ vaccination: Harvesting low hanging fruit on the cancer immunotherapy tree.
Sheen MR; Fiering S
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2019 Jan; 11(1):e1524. PubMed ID: 29667346
[TBL] [Abstract][Full Text] [Related]
16. Irreversible electroporation: ready for prime time?
Lu DS; Kee ST; Lee EW
Tech Vasc Interv Radiol; 2013 Dec; 16(4):277-86. PubMed ID: 24238383
[TBL] [Abstract][Full Text] [Related]
17. Expression of costimulatory and inhibitory receptors in FoxP3
Toker A; Ohashi PS
Adv Cancer Res; 2019; 144():193-261. PubMed ID: 31349899
[TBL] [Abstract][Full Text] [Related]
18. Immuno-oncology-101: overview of major concepts and translational perspectives.
Allard B; Aspeslagh S; Garaud S; Dupont FA; Solinas C; Kok M; Routy B; Sotiriou C; Stagg J; Buisseret L
Semin Cancer Biol; 2018 Oct; 52(Pt 2):1-11. PubMed ID: 29428479
[TBL] [Abstract][Full Text] [Related]
19. Harnessing the immunomodulatory effect of thermal and non-thermal ablative therapies for cancer treatment.
Bastianpillai C; Petrides N; Shah T; Guillaumier S; Ahmed HU; Arya M
Tumour Biol; 2015 Dec; 36(12):9137-46. PubMed ID: 26423402
[TBL] [Abstract][Full Text] [Related]
20. Cancer-associated fibroblast-targeted strategy enhances antitumor immune responses in dendritic cell-based vaccine.
Ohshio Y; Teramoto K; Hanaoka J; Tezuka N; Itoh Y; Asai T; Daigo Y; Ogasawara K
Cancer Sci; 2015 Feb; 106(2):134-42. PubMed ID: 25483888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
